Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.

@article{Garvey2001SomatosensoryEP,
  title={Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.},
  author={Marjorie A Garvey and Carla Toro and Steven Goldstein and Gheona Altarescu and Edythe A. Wiggs and Mark Hallett and Raphael Schiffmann},
  journal={Neurology},
  year={2001},
  volume={56 3},
  pages={391-4}
}
The authors compared stretch-evoked somatosensory evoked potentials (SEP) of 18 type 3 Gaucher disease (GD3) patients (two with progressive myoclonus epilepsy [PME]) with 22 age-matched normal controls and six patients with type 1 (nonneuronopathic) Gaucher disease (GD1). The mean P1-N2 SEP amplitude in GD3 patients was significantly larger than the SEP in controls and in GD1 patients, and there was a significant negative correlation between SEP amplitude and the IQ of GD3 patients. The authors… CONTINUE READING

Similar Papers

Loading similar papers…